Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID389 | TGIFTDQVLSVLKGEE | Apolipoprotein C-II | Plasma | 868.46 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID390 | TGIFTDQVLSVL | Apolipoprotein C-II | Plasma | 646.86 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID391 | GIFTDQVLSVLKGEE | Apolipoprotein C-II | Plasma | 817.93 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID392 | GIFTDQVLSVL | Apolipoprotein C-II | Plasma | 596.33 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID393 | FTDQVLSVLKGEE | Apolipoprotein C-II | Plasma | 732.88 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID394 | TDQVLSVLKGEE | Apolipoprotein C-II | Plasma | 659.35 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID395 | DQVLSVLKGEE | Apolipoprotein C-II | Plasma | 608.82 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID396 | TQQPQQDEMPSPTF | Apolipoprotein C-II | Plasma | 817.36 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID397 | TQQPQQDEMPSPT | Apolipoprotein C-II | Plasma | 743.82 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID398 | FLTQVKESL | Apolipoprotein C-II | Plasma | 532.8 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID399 | SYWESAKTAAQ | Apolipoprotein C-II | Plasma | 621.29 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID2219 | GIFTDQVLSVLKGEE | Apolipoprotein C-II | Serum | 1633.8563 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID4979 | FLTQVKESLSSY | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4980 | FLTQVKESLSSYWE | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7331 | SYWESAKTAAQN | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7383 | TGIFTDQVLSVLKGEE | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7558 | TQQPQQDEMPSPTF | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7559 | TQQPQQDEMPSPTFL | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7693 | TYLPAVDEKL | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7694 | TYLPAVDEKLRD | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7857 | VKESLSSYWESAKTAAQN | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8132 | WESAKTAAQNL | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8133 | WESAKTAAQNLYE | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8266 | YEKTYLPAVDEK | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8267 | YEKTYLPAVDEKL | Apolipoprotein C-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8773 | DQVLSVLKGEE | Apolipoprotein C-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9285 | TDQVLSVLKGEE | Apolipoprotein C-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9327 | TQQPQQDEMPSPTFLT | Apolipoprotein C-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9574 | TDQVLSVLKGEE | Apolipoprotein C-II | Serum | 659.35 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |